ANBOT
EW icon

American National Bank of Texas’s Edwards Lifesciences EW Stock Holding History

American National Bank of Texas’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260K Sell
3,010
-305
-9% -$27.1K 0.24% 43
2026
Q2 		$300K Buy
3,315
+61
+2% +$5.11K 0.27% 43
2026
Q1 		$261K Sell
3,254
-598
-16% -$49.3K 0.25% 50
2025
Q4 		$328K Sell
3,852
-246
-6% -$20.2K 0.32% 38
2025
Q3 		$319K Buy
+4,098
New +$320K 0.3% 46

Other funds holding EW

WCG
Weaver Consulting Group Huntington Beach, California $514M AUM 11.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
BST
Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return

American National Bank of Texas's EW Position: Q3 2026 in Review

American National Bank of Texas reduced its Edwards Lifesciences (EW) stake by 9.2% in Q3 2026, selling an estimated $27.1K and leaving 3,010 shares worth $260K. The position accounts for 0.24% of the portfolio, ranked #43.

American National Bank of Texas first reported a position in EW in Q3 2025 and has held it in 5 quarters since. The position peaked at $328K in Q4 2025. 39 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • American National Bank of Texas held 3,010 shares of Edwards Lifesciences worth $260K as of Q3 2026.
  • American National Bank of Texas sold 305 Edwards Lifesciences shares in Q3 2026, an estimated $27.1K.
  • Edwards Lifesciences made up 0.24% of American National Bank of Texas's portfolio in Q3 2026, its #43 holding.
  • American National Bank of Texas first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 5 quarters since.
  • American National Bank of Texas's Edwards Lifesciences position peaked at $328K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on American National Bank of Texas's 13F filing for Q3 2026, filed 7 Oct 2026.